Where modern science meets ancient wisdom
The Katharsis Team is a living example of synchronicity, the result of a series of coincidences that continues to unite like-minded people committed to building resilient models of wellbeing rooted in science and spirituality.
Alexander Lebedev, MD PhD
Chief Executive Officer
Alexander is a psychiatrist and neuroscientist with over 15 years experience in clinical and biomedical research. His academic work is focused on understanding complex relationships between global societal dynamics and people's health, wellbeing, beliefs and decision-making. As a part of his academic career, he published dozens of peer-reviewed articles on brain imaging, socionomics, psychopharmacology, psychedelics and coordinated several research studies, including Sweden’s first clinical trial investigating psilocybin's potential to treat depression. Alexander's mission is to develop novel wellbeing models that foster individual and societal resilience.
Emily Biesmans, MD
Chief Experience Officer
Emily Biesmans, British/Belgian national, holds a Bachelor in Biomedical Sciences from Manchester University and a M.D (Medical Doctorate) from the Medical University of Warsaw. Emily completed her post-graduate medical training at Mater Dei Hospital in Malta. Emily has experience with a number of plant medicines, through which she received her own healing and life changing experiences. Emily has trained in therapeutic work with non-ordinary states of consciousness and has received certified training in Ibogaine assisted therapy by Jonathan Dickinson, director of GITA (Global Ibogaine Therapy Alliance). Being passionate about nutrition and mind-body medicine, Emily is also pursuing further training in Functional Medicine.
Amir Chalaby, MD
Chief Operation & Medical Officer
Amir achieved his Doctor of Medicine degree from Poznan University of Medical Sciences. After graduation he finished his core training in Malta where he gained experience in the core branch of Internal Medicine, in particular Cardiology and Emergency medicine. Pursuing his interests in the human psyche, Amir went on to work as a psychiatry resident in Norway. Throughout his studies of the human mind, Amir became increasingly interested in non-ordinary states of consciousness and went on to receive training in Ibogaine-Assisted Therapy and Ketamine Assisted Psychotherapy.
Amir's mission is to amalgamate traditional psychiatry with therapeutic work through altered states of consciousness.
Luigi Espasiano, MD
Chief Business Officer
Luigi received his MD from the University of Naples. In 2018 Luigi worked as a clinical fellow at Imperial College London Psychedelic Research Group where he worked on pioneering psilocybin trial. To deepen his clinical experience, Luigi took resident positions in Psychiatry at Geneva University Hospital and Anaesthesiology in Milano. Luigi’s ambition is to create safe access to psychedelic therapies and build an integral model of health care.